Acer Therapeutics Inc. (NasdaqCM:ACER) entered into a purchase contract to acquire Lantana Investments, LLC from Jacaranda Investments, Inc. for $0.64 million on October 19, 2018. Under the terms, Acer Therapeutics will issue $0.44 million promissory note and a $0.20 million promissory note. The transaction is expected to close on October 26, 2018. Acer Therapeutics Inc. (NasdaqCM:ACER) completed the acquisition of Lantana Investments, LLC from Jacaranda Investments, Inc. on December 31, 2018.